Why the study?
Infections of cardiac implantable electronic devices are serious, potentially deadly, and costly complications, making the identification of risk factors essential to choose alternative therapies and reduce infection risk.
What are the patient and procedural risk factors for cardiac implantable electronic device (CIED) infections?
What are the patient and procedural risk factors for cardiac implantable electronic device (CIED) infections?
Identifying patient and procedural risk factors for CIED infections is crucial for prevention, potentially reducing patient mortality and healthcare costs.
<ns3:p>Each year, 1.2-1.4 million devices such as pacemakers, cardioverter-defibrillators and devices with the resynchronization function are implanted, and for some time also electrodes for stimulating the His bundle or the left bundle branch. One of the most serious complications of electrotherapy is infections of implantable systems (CIED infection). Knowing the risk factors give the option to choose other therapies and reduce the risk of infection. Important patient-related factors include: diabetes, heart and/or kidney failure or dysfunction, COPD, the presence of neoplastic disease and use of anticoagulation in the short term before the procedure. According to the research, the number of treatments performed in the implanting centre and by the operator, as well as the number of electrodes, the method of preparing the operating field, or the method of inserting the electrodes, also seems to be important in the development of CIED infection. It is better to prevent the infection than to cure it, as possible complications can be deadly for the patient and costly for the health system.</ns3:p>
No takes yet. Share an insight, caveat, or question.
Łukasz Grydz (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: